DUSTIN MAYFIELD: Open Payments
NPI 1942882808 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$254 in 9 payments from 8 companies in 2025. Trend: 2023 $55 · 2024 $218 · 2025 $254
Food & beverage: $254
| Company | Payments | Amount |
|---|---|---|
| ARGENX US, INC. | 1 | $88 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Melinta Therapeutics, LLC | 1 | $22 |
| Lundbeck LLC | 1 | $21 |
| Eisai Inc. | 1 | $20 |
| PFIZER INC. | 1 | $19 |
| Amgen Inc. | 1 | $18 |
Products named: VYVGART, ILARIS, Rezzayo, GLASSIA, VYEPTI, ENTYVIO, Leqembi, OCTAGAM IMMUNE GLOBULIN (HUMAN).
Industry payments across TN — which companies pay providers there.
